Brain catalase in the streptozotocin-rat model of sporadic Alzheimer’s disease treated with the iron chelator–monoamine oxidase inhibitor, M30

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of neural transmission

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00702-014-1307-yPMID 25252744
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies.

  2014cited by this paper
• Mild Oxidative Stress Induces Redistribution of BACE1 in Non-Apoptotic Conditions and Promotes the Amyloidogenic Processing of Alzheimer’s Disease Amyloid Precursor Protein

  2013cited by this paper
• Alzheimer's disease and insulin resistance: translating basic science into clinical applications.

  2013cited by this paper
• Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.

  2013cited by this paper
• In vitro mitochondrial failure and oxidative stress mimic biochemical features of Alzheimer disease.

  2013cited by this paper
• Role of metal ions in the self-assembly of the Alzheimer's amyloid-β peptide.

  2013cited by this paper
• Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art.

  2013cited by this paper
• Novel 5′ Untranslated Region Directed Blockers of Iron-Regulatory Protein-1 Dependent Amyloid Precursor Protein Translation: Implications for Down Syndrome and Alzheimer's Disease

  2013cited by this paper
• Intranasal insulin therapy for cognitive impairment and neurodegeneration: current state of the art

  2013cited by this paper
• Effects of novel neuroprotective and neurorestorative multifunctional drugs on iron chelation and glucose metabolism

  2012cited by this paper
• What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research

  2012cited by this paper
• Neuroprotective efficacy of Nardostachys jatamansi and crocetin in conjunction with selenium in cognitive impairment

  2012cited by this paper
• The Novel Multi-Target Iron Chelating-Radical Scavenging Compound M30 Possesses Beneficial Effects on Major Hallmarks of Alzheimer's Disease

  2012cited by this paper
• P1‐257: Cannabinoid effects on nonassociative learning in mice

  2012cited by this paper
• Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.

  2011cited by this paper
• Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain.

  2011cited by this paper
• Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer’s disease: a long-term follow up study

  2011cited by this paper
• P3‐184: Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin‐administered rats

  2011cited by this paper
• The link between iron, metabolic syndrome, and Alzheimer’s disease

  2011cited by this paper
• The Novel Multifunctional, Iron-Chelating Drugs M30 and HLA20 Protect Pancreatic β-Cell Lines from Oxidative Stress Damage

  2010cited by this paper
• Effect of chronic treatment of carvedilol on oxidative stress in an intracerebroventricular streptozotocin induced model of dementia in rats

  2009cited by this paper
• Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats.

  2009cited by this paper
• A study of brain insulin receptors, AChE activity and oxidative stress in rat model of ICV STZ induced dementia.

  2009cited by this paper
• Antioxidant capacity in rat brain after intracerebroventricular treatment with streptozotocin and alloxan--a preliminary study.

  2008cited by this paper
• Antioxidant capacity in rat brain after ICV treatment with streptozotocin and alloxan — a preliminary study

  2008cited by this paper
• Reduced Brain Antioxidant Capacity in Rat Models of Betacytotoxic-Induced Experimental Sporadic Alzheimer’s Disease and Diabetes Mellitus

  2007cited by this paper
• Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach.

  2007cited by this paper
• Neuropsychiatric disorders : an integrative approach

  2007cited by this paper
• Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer's disease and diabetes mellitus.

  2007cited by this paper
• Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein

  2007cited by this paper
• M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson's disease.

  2006cited by this paper
• Chronic administration of pioglitazone attenuates intracerebroventricular streptozotocin induced-memory impairment in rats.

  2006cited by this paper
• Involvement of multiple survival signal transduction pathways in the neuroprotective, neurorescue and APP processing activity of rasagiline and its propargyl moiety.

  2006cited by this paper
• Alzheimer‐like changes in protein kinase B and glycogen synthase kinase‐3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway

  2006cited by this paper
• Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats.

  2006cited by this paper
• Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders.

  2006cited by this paper
• Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's diseases.

  2006cited by this paper
• Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.

  2005cited by this paper
• Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders.

  2005cited by this paper
• Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer's, Parkinson's, and other neurodegenerative diseases.

  2005cited by this paper
• Novel multifunctional neuroprotective iron chelator‐monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition

  2005cited by this paper
• Neuroprotection via pro‐survival protein kinase C isoforms associated with Bcl‐2 family members

  2004cited by this paper
• Redox Metals in Alzheimer's Disease

  2004influential reference
• Oxidative Stress and Redox‐Active Iron in Alzheimer's Disease

  2004cited by this paper
• Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats.

  2004cited by this paper
• Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats

  2003cited by this paper
• Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats.

  2001cited by this paper
• Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment.

  2001cited by this paper
• Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth.

  2001cited by this paper
• The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.

  2001cited by this paper
• Catalases and thioredoxin peroxidase protect Saccharomyces cerevisiae against Ca2+‐induced mitochondrial membrane permeabilization and cell death

  2000cited by this paper
• Understanding the structure and function of catalases: clues from molecular evolution and in vitro mutagenesis.

  1999cited by this paper
• Generation of hydrogen peroxide precedes loss of mitochondrial membrane potential during DNA alkylation‐induced apoptosis

  1999cited by this paper
• Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis.

  1999cited by this paper
• Overexpression of Catalase in Cytosolic or Mitochondrial Compartment Protects HepG2 Cells against Oxidative Injury*

  1999cited by this paper
• Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

  1998cited by this paper
• Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease.

  1998cited by this paper
• Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis

  1997cited by this paper
• Decreased Catalase Activity but Unchanged Superoxide Dismutase Activity in Brains of Patients with Dementia of Alzheimer Type

  1995cited by this paper
• Susceptibility of Brains from Patients with Alzheimer's Disease to Oxygen-Stimulated Lipid Peroxidation and Differential Scanning Calorimetry

  1992cited by this paper
• Early Markers in Parkinson’s and Alzheimer’s Diseases

  1991cited by this paper
• Senile dementia of Alzheimer’s type and Parkinson’s disease: neurochemical overlaps and specific differences

  1990cited by this paper
• Reflection of changes in membrane constituents in various regions of Alzheimer brains to differential scanning thermograms.

  1990cited by this paper
• Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior.

  1989cited by this paper
• Monoaminerge Läsion bei seniler Demenz vom Alzheimer-Typ (SDAT): Vorläufige Befunde

  1988cited by this paper
• Insulin in the brain.

  1987cited by this paper
• Measurement of catalase activity in tissue extracts.

  1970cited by this paper
• Catalase: Physical and chemical properties, mechanism of catalysis, and physiological role.

  1970cited by this paper

• Neuroprotective activity of alcoholic extract of Operculina turpethum roots in aluminum chloride-induced Alzheimer’s disease in rats

  2024cites this paper
• Neuroprotective Effects of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors (Gliflozins) on Diabetes-Induced Neurodegeneration and Neurotoxicity: A Graphical Review

  2024cites this paper
• Is metformin neuroprotective against diabetes mellitus-induced neurodegeneration? An updated graphical review of molecular basis

  2023cites this paper
• The effect of ghrelin on antioxidant status in the rat’s model of Alzheimer’s disease induced by amyloid-beta

  2022cites this paper
• Synaptic loss and gliosis in the nucleus tractus solitarii with streptozotocin-induced Alzheimer's disease.

  2022cites this paper
• Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer’s Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside

  2021cites this paper
• The protective, rescue and therapeutic potential of multi-target iron-chelators for retinitis pigmentosa.

  2021cites this paper
• Failure of the Brain Glucagon-Like Peptide-1-Mediated Control of Intestinal Redox Homeostasis in a Rat Model of Sporadic Alzheimer’s Disease

  2021cites this paper
• Illumination with 630 nm Red Light Reduces Oxidative Stress and Restores Memory by Photo-Activating Catalase and Formaldehyde Dehydrogenase in SAMP8 Mice

  2019cites this paper
• Iron Exposure and the Cellular Mechanisms Linked to Neuron Degeneration in Adult Mice

  2019cites this paper
• Iron chelator deferiprone rescues memory deficits, hippocampal BDNF levels and antioxidant defenses in an experimental model of memory impairment

  2018cites this paper
• EVALUATION OF THE POSSIBLE ANTIOXIDANT EFFECTS OF PEGANUM HARMALA AND GINKGO BILOBA IN AMELIORATING ALZHEIMER’S DISEASE IN RAT MODEL

  2018cites this paper
• Neuroprotection and cognitive enhancement by treatment with γ-oryzanol in sporadic Alzheimer's disease

  2017cites this paper
• The effects of lipoic acid on redox status in brain regions and systemic circulation in streptozotocin-induced sporadic Alzheimer’s disease model

  2017cites this paper
• Tramadol ameliorates behavioural, biochemical, mitochondrial and histological alterations in ICV-STZ-induced sporadic dementia of Alzheimer’s type in rats

  2017cites this paper
• Blunted Respiratory Responses in the Streptozotocin-Induced Alzheimer’s Disease Rat Model

  2017cites this paper
• [Disruption of iron homeostasis and relevant pharmacotherapies in Alzheimer’s disease].

  2016cites this paper
• Binge ethanol exposure increases the Krüppel-like factor 11-monoamine oxidase (MAO) pathway in rats: Examining the use of MAO inhibitors to prevent ethanol-induced brain injury.

  2016cites this paper
• Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β‐amyloid in ageing and Alzheimer's disease

  2016cites this paper
• A Novel Antioxidant Multitarget Iron Chelator M30 Protects Hepatocytes against Ethanol-Induced Injury

  2015cites this paper
• Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease.

  2015cites this paper
• International publications of authors from Bosnia and Herzegovina in Current Contents indexed publications in the second half of 2014

  2015cites this paper
• Title A Novel Antioxidant Multitarget Iron Chelator M 30 ProtectsHepatocytes against Ethanol-Induced Injury

  2015cites this paper